AU2001237482A1 - Continuous method for preparing pharmaceutical granules - Google Patents

Continuous method for preparing pharmaceutical granules

Info

Publication number
AU2001237482A1
AU2001237482A1 AU2001237482A AU3748201A AU2001237482A1 AU 2001237482 A1 AU2001237482 A1 AU 2001237482A1 AU 2001237482 A AU2001237482 A AU 2001237482A AU 3748201 A AU3748201 A AU 3748201A AU 2001237482 A1 AU2001237482 A1 AU 2001237482A1
Authority
AU
Australia
Prior art keywords
continuous method
preparing pharmaceutical
pharmaceutical granules
granules
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237482A
Other languages
English (en)
Inventor
Jean-Claude Le Thiesse
Stephane Martin-Letellier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhodia Chimie SAS
Original Assignee
Rhodia Chimie SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie SAS filed Critical Rhodia Chimie SAS
Publication of AU2001237482A1 publication Critical patent/AU2001237482A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001237482A 2000-02-04 2001-01-24 Continuous method for preparing pharmaceutical granules Abandoned AU2001237482A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001457A FR2804603B1 (fr) 2000-02-04 2000-02-04 Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
FR0001457 2000-02-04
PCT/FR2001/000225 WO2001056549A1 (fr) 2000-02-04 2001-01-24 Procede continu pour preparer des granules pharmaceutiques

Publications (1)

Publication Number Publication Date
AU2001237482A1 true AU2001237482A1 (en) 2001-08-14

Family

ID=8846688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237482A Abandoned AU2001237482A1 (en) 2000-02-04 2001-01-24 Continuous method for preparing pharmaceutical granules

Country Status (9)

Country Link
US (1) US20030224057A1 (fr)
EP (1) EP1251830A1 (fr)
JP (1) JP2004500193A (fr)
CN (1) CN1419443A (fr)
AU (1) AU2001237482A1 (fr)
CA (1) CA2399034A1 (fr)
FR (1) FR2804603B1 (fr)
MX (1) MXPA02007458A (fr)
WO (1) WO2001056549A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168666A1 (fr) 2008-09-25 2010-03-31 Gambro Lundia AB Membrane irradiée pour expansion cellulaire
EP2177603A1 (fr) 2008-09-25 2010-04-21 Gambro Lundia AB Dispositif pour expansion cellulaire rénale
EP2168614B1 (fr) 2008-09-25 2012-02-15 Gambro Lundia AB Rein bio-artificiel hybride
EP2168668A1 (fr) 2008-09-25 2010-03-31 Gambro Lundia AB Membrane pour expansion cellulaire
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (fr) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Formulations d'hormones substitutives combinées naturelles et traitement hormonal substitutif
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
WO2017173071A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone stéroïde
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN112978407B (zh) * 2021-02-24 2023-12-22 华诺医药(广州)有限公司 一种中西药物颗粒降压式落料收集设备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8606762D0 (en) * 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
DE19522899C1 (de) * 1995-06-23 1996-12-19 Hexal Pharmaforschung Gmbh Verfahren zum kontinuierlichen Ersintern eines Granulats
US6242006B1 (en) * 1996-07-16 2001-06-05 Gist-Brocades B.V. β-lactam granules free of organic solvents
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe

Also Published As

Publication number Publication date
EP1251830A1 (fr) 2002-10-30
CA2399034A1 (fr) 2001-08-09
FR2804603B1 (fr) 2004-01-23
MXPA02007458A (es) 2003-01-28
US20030224057A1 (en) 2003-12-04
JP2004500193A (ja) 2004-01-08
FR2804603A1 (fr) 2001-08-10
CN1419443A (zh) 2003-05-21
WO2001056549A1 (fr) 2001-08-09

Similar Documents

Publication Publication Date Title
AU2001237482A1 (en) Continuous method for preparing pharmaceutical granules
AU2001252588A1 (en) Method for preparing microsphere
AU2002218220A1 (en) Method for producing powdery formulations
IL153282A0 (en) Method for preparing a pharmaceutical composition
AU2001249061A1 (en) Pharmaceutical packaging system
AU2002357049A1 (en) Methods for preparing 0-desmethylvenlafaxine
AU2001283164A1 (en) System for continuously forming center filled gum
AU2001236515A1 (en) Advanced vitrification system filling process
AU2002230470A1 (en) Process for preparing pouches
AU2001239243A1 (en) Method for producing nanosuspensions
AU2001263004A1 (en) System for continuously producing gum
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2001233699A1 (en) Method for selecting products
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU4997000A (en) Granulation process
EP1298117A3 (fr) Procédé de préparation de bromofluorènes
AU2002333276A1 (en) Drugs for vasculopaties
AU2002241758A1 (en) Drug screening system
AU3656900A (en) Granulation method
AU2002222604A1 (en) Process for preparing substance GM-95
AU2001292578A1 (en) Pharmaceutical compounds
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU3547001A (en) Method for producing pharmaceutical dosage forms
AU1283001A (en) Method for producing alkylhalogenosilanes
AU1141501A (en) Method for producing hydroxymethylpyridines